NA Akwe

Dr. NA Akwe


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2018 in Journal of Cardiology & Current Research
Verified
Journal Article
Open access
PDF file
NANA Akwe
NA Akwe
AKAmy Miller1 Erin Kim1
Amy Miller1 Erin Kim1
Non-cardiac causes of elevated troponins are often overlooked, yet elevated troponins have been shown to closely correlate with the prognosis of these conditions. The clinical significance of elevated troponins in non-cardiac conditions are not completely known. Also, it is still unclear if these clinical conditions need to be managed differently when they lead to an increase in troponin levels. Some of the non-cardiac conditions in which elevated troponins are commonly found include: pulmonary embolism, end stage renal disease, Sepsis/ Systemic inflammatory response syndrome (SIRS) and critically ill patient, rhabdomyolysis, physical exercise, burns, drug toxicity and stroke. This article discusses the suggested etiology of elevated cardiac troponins in these conditions and the prognostic values they carry.

4 January 2021 in Southern Medical Journal
Verified
Journal Article
Closed access
YSYoo Mee Shin
Yoo Mee Shin
DHDaniel P. Hunt
Daniel P. Hunt
NANA Akwe
NA Akwe
Before the coronavirus disease 2019 (COVID-19) pandemic, vaping-related illness was the prevailing public health concern. The incidence of vaping-related illnesses—mainly e-cigarette, or vaping, product use–associated lung injury (EVALI)—went from a peak in September 2019 to a low in February 2020, and the Centers for Disease Control and Prevention decided to discontinue the collection of...

28 December 2017 in Journal of Cardiology & Current Research
Verified
Journal Article
Open access
PDF file
NANA Akwe
NA Akwe
AKAmy Miller1 Erin Kim1
Amy Miller1 Erin Kim1

31 May 2017 in Journal of Lung, Pulmonary & Respiratory Research
Verified
Journal Article
Open access
PDF file
NANA Akwe
NA Akwe
Cocaine is a powerful central nervous system stimulant extracted from the leaves of Erythroxylon coca, a native plant of the Andean and Amazon regions in South America. Cocaine has multiple effects on the lungs, both acute and chronic. Effects of cocaine to the lungs depend on the route of administration (oral, nasal, intravenous), dose size, frequency of exposure, and presence of associated substances like heroin, talc or marijuana. These effects include barotrauma; airway injury; asthma; pulmonary edema; pulmonary hemorrhage; "crack lung", eosinophilic lung disease; bronchiolitis obliterans, organized pneumonia, interstitial lung disease; pulmonary hypertension; emphysema; both infectious and aspiration pneumonias; and tumors. The most commonly encountered respiratory symptoms include cough productive of dark sputum (carbonaceous material), chest pain, dyspnea, hemoptysis, wheezing, and exacerbation of asthma.

1 October 2024 in Journal of Brown Hospital Medicine
Verified
Journal Article
Open access
PDF file
NANA Akwe
NA Akwe
Background: Cardiac arrest is a prevalent event with low survival rates, both in out-of-hospital and in-hospital settings. There is a lack of specific training programs addressing team dynamics and leadership skills during resuscitation events, creating a clinical gap. This project aimed to enhance team dynamics and improve leadership skills during IHCA resuscitation events. Methods: We implemented the Mock Code Project for resident physicians from our Internal Medicine Residency Programs in the simulation center (i.e., in a controlled environment) to address this gap. Multidisciplinary team mock code scenarios were created for residents, allowing them to lead resuscitation simulations. The scenarios were based upon common conditions encountered during codes (Cardiac arrest). Trained evaluators provided real-time feedback, and pre-and post-surveys were conducted to assess team perception and gather feedback. Results: Baseline data revealed that 98.6% (143 of 145 residents total) felt uncertain or lacked confidence in leading effective codes in our hospital prior to the intervention. Post-test survey outcome data revealed that 95.1% of participants (136 residents of 143) reported that the sessions challenged their skills at leading codes and improved their skills at managing resuscitation teams. Conclusion: Organized codes with clear roles, responsibilities, bed positioning, and clear leadership significantly improve closed-loop communication, effective team interaction, and patient outcomes. The Mock Code Project fills the gap in training programs by focusing on team dynamics and leadership skills during IHCA resuscitation. Ongoing evaluations and feedback ensure continual improvement in resident confidence and skills. Implementing organized codes benefits residents and healthcare teams, ultimately improving patient care during IHCA. Well-designed mock code scenarios with real-time feedback from senior physicians are an effective way for trainees to develop these skills and this awareness without compromising patient safety.

5 September 2025 in Cureus
Verified
Journal Article
Open access
PDF file
NANA Akwe
NA Akwe
KFKimela Fongeh
Kimela Fongeh
SJSarah Jung
Sarah Jung
MHMary Ann Kirkconnell Hall
Mary Ann Kirkconnell Hall
VPViniya Patidar
Viniya Patidar
KFKimela I. Fongeh
Kimela I. Fongeh
Obesity is a chronic, relapsing, and multifactorial disease with rising prevalence and substantial health and economic burdens. Despite significant advances in both medical and surgical treatments, clinicians and patients still face a lack of clear, comparative guidance for tailoring therapy based on individual risk factors, disease severity, and comorbidities. This review synthesizes current evidence on lifestyle and behavioral interventions, pharmacologic therapies (including glucagon-like peptide-1 [GLP-1] receptor agonists), and surgical approaches. Key clinical considerations in treatment selection include body mass index, eligibility for surgical or non-surgical interventions, patient preferences, tolerance for side effects, and the long-term impact on quality of life. While lifestyle and behavioral modifications alone pose minimal risks, they are considerably less effective than when combined with pharmacologic or surgical/endoscopic treatments. Current pharmacotherapies, particularly GLP-1 receptor agonists and dual agonists such as tirzepatide, represent a paradigm shift in non-surgical weight management, though questions remain regarding their long-term efficacy and safety. Bariatric surgery offers the most effective and durable weight loss outcomes, significantly improving obesity-related comorbidities and long-term survival. However, it carries higher upfront risks, potential complications, nutritional deficiencies, and increased costs. Ultimately, integrated treatment models that combine lifestyle, pharmacologic, and/or surgical strategies are likely to offer the most effective and sustainable outcomes in managing obesity. Our review highlights the importance of an individualized, evidence-based, and multimodal strategy to effectively manage obesity and address its complexity. Continued research is essential to refine patient selection and improve integration of treatment options, ultimately supporting more personalized and effective obesity care.